By Matt Grossman 



  Johnson & Johnson on Thursday raised its revenue and earnings guidance for 2020 compared with forecasts it had issued in April. 


  The global health-products giant now expects adjusted earnings per share of $7.75 to $7.95 for the year, compared with the earlier forecast of $7.50 to $7.90. Analysts polled by FactSet were anticipating adjusted earnings per share of $7.75. 


  J&J now expects 2020 revenue of $79.9 billion to $81.4 billion, up from the prior guidance range of $77.5 billion to $80.5 billion. Analysts had forecast revenue of $79.77 billion. 


  The company says the new guidance includes the estimated impact of the coronavirus pandemic. 


  Write to Matt Grossman at matt.grossman@wsj.com